The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Zeidler, Phil
    Non Executive born in September 1968
    Individual (8 offsprings)
    Officer
    2024-05-01 ~ now
    OF - Director → CIF 0
  • 2
    Fitzsimons, Morgan
    Cmo born in February 1985
    Individual (4 offsprings)
    Officer
    2020-09-17 ~ now
    OF - Director → CIF 0
  • 3
    Reynolds, Kelly
    Director born in June 1986
    Individual (3 offsprings)
    Officer
    2020-01-14 ~ now
    OF - Director → CIF 0
    Kelly Reynolds
    Born in June 1986
    Individual (3 offsprings)
    Person with significant control
    2020-01-14 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 4
    Cox, Chantal
    Investment Manager born in September 1991
    Individual (1 offspring)
    Officer
    2023-03-03 ~ now
    OF - Director → CIF 0
  • 5
    Gibbs, Will
    Fund Manager born in August 1989
    Individual (2 offsprings)
    Officer
    2024-06-28 ~ now
    OF - Director → CIF 0
Ceased 2
  • 1
    Reynolds, Guy David
    Ceo born in March 1982
    Individual (9 offsprings)
    Officer
    2020-09-08 ~ 2023-03-03
    OF - Director → CIF 0
  • 2
    Schmid, Peter
    Professor Of Cancer Medicine born in August 1971
    Individual (1 offspring)
    Officer
    2020-10-09 ~ 2023-03-03
    OF - Director → CIF 0
parent relation
Company in focus

PERCI HEALTH LTD

Previous name
RESILI LTD - 2020-12-09
Standard Industrial Classification
62090 - Other Information Technology Service Activities
Brief company account
Average Number of Employees
172023-02-01 ~ 2023-12-31
142022-02-01 ~ 2023-01-31
Intangible Assets
107,437 GBP2023-12-31
120,952 GBP2023-01-31
Fixed Assets
107,437 GBP2023-12-31
120,952 GBP2023-01-31
Debtors
Current
803,750 GBP2023-12-31
130,365 GBP2023-01-31
Cash at bank and in hand
1,345,062 GBP2023-12-31
198,838 GBP2023-01-31
Current Assets
2,148,812 GBP2023-12-31
329,203 GBP2023-01-31
Creditors
Current, Amounts falling due within one year
-189,659 GBP2023-12-31
-78,379 GBP2023-01-31
Net Current Assets/Liabilities
1,959,153 GBP2023-12-31
250,824 GBP2023-01-31
Total Assets Less Current Liabilities
2,066,590 GBP2023-12-31
371,776 GBP2023-01-31
Net Assets/Liabilities
2,066,590 GBP2023-12-31
371,776 GBP2023-01-31
Equity
Called up share capital
3 GBP2023-12-31
2 GBP2023-01-31
Share premium
5,210,550 GBP2023-12-31
2,860,547 GBP2023-01-31
Retained earnings (accumulated losses)
-3,143,963 GBP2023-12-31
-2,488,773 GBP2023-01-31
Equity
2,066,590 GBP2023-12-31
371,776 GBP2023-01-31
Intangible Assets - Gross Cost
Development expenditure
147,437 GBP2023-12-31
147,437 GBP2023-01-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
40,000 GBP2023-12-31
26,485 GBP2023-01-31
Intangible Assets
Development expenditure
107,437 GBP2023-12-31
120,952 GBP2023-01-31
Trade Debtors/Trade Receivables
Current
98,150 GBP2023-12-31
45,856 GBP2023-01-31
Other Debtors
Current
1 GBP2023-12-31
84,509 GBP2023-01-31
Prepayments/Accrued Income
Current
21,916 GBP2023-12-31
Debtors - Deferred Tax Asset
Current
683,683 GBP2023-12-31
Bank Overdrafts
-2,755 GBP2023-12-31
Cash and Cash Equivalents
1,342,307 GBP2023-12-31
198,838 GBP2023-01-31
Bank Overdrafts
Current
2,755 GBP2023-12-31
Trade Creditors/Trade Payables
Current
69,666 GBP2023-12-31
24,146 GBP2023-01-31
Taxation/Social Security Payable
Current
50,685 GBP2023-12-31
22,631 GBP2023-01-31
Other Creditors
Current
5,793 GBP2023-12-31
5,844 GBP2023-01-31
Accrued Liabilities/Deferred Income
Current
60,760 GBP2023-12-31
25,758 GBP2023-01-31
Creditors
Current
189,659 GBP2023-12-31
78,379 GBP2023-01-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2,785,407 shares2023-12-31
2,191,550 shares2023-01-31
Par Value of Share
Class 1 ordinary share
0.0000012023-02-01 ~ 2023-12-31

  • PERCI HEALTH LTD
    Info
    RESILI LTD - 2020-12-09
    Registered number 12402935
    1 Vincent Square, London, London SW1P 2PN
    Private Limited Company incorporated on 2020-01-14 (5 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-13
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.